To protect patients amid a changing health care landscape, ophthalmologists must be vocal with policymakers about the barriers that prevent patients from receiving proper care.While the Big Beautiful Bill, which was signed into law in July, offers phys…
Tenpoint Therapeutics, Ltd. to Participate in Four Upcoming Investor Conferences
LONDON & SEATTLE–(BUSINESS WIRE)– #InvestorConference–Tenpoint Therapeutics, Ltd. to Participate in Four Upcoming Investor Conferences
Study: New Antisepsis Approach for Eye Injections Equals Old
Retina specialists are shifting from povidone iodine to chlorhexidine to prevent infections after eye injections. A new study says either approach is effective. Medscape Medical News
FDA approves Eydenzelt as biosimilar referencing Eylea
Editor’s note: This is a developing news story. Please check back soon for updates.The FDA approved Eydenzelt, a biosimilar referencing Eylea, for the treatment of four retinal diseases, according to a press release from Celltrion.These conditions incl…
Broadwood Partners Issues Letter to STAAR Surgical’s Board Questioning Its Diligence in Rush to Reaffirm Support for Alcon Sale
NEW YORK–(BUSINESS WIRE)–Broadwood Partners, L.P. and its affiliates (collectively, “Broadwood”) today issued the following letter to the Board of Directors (the “Board”) of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA). Broadwood,…
Study to focus on atropine drops to delay myopia onset
BOSTON — A study of atropine eye drops to delay the onset of pediatric myopia has received federal grants totaling $25 million and will be conducted by researchers at the University of Houston and The Ohio State University.“A study like this has never …